Related Experiment Video
Updated: Sep 2, 2026

Remote Laboratory Management: Respiratory Virus Diagnostics
Published on: April 6, 2019
Bundibugyo at the Border: The 2026 Ebola Outbreak and the Case for Pre-emptive Countermeasure Equity
Adamu Safiyanu Maikifi1, Auwal Rabiu Auwal2, Abubakar Sunusi Ishak3
1Department of Pharmaceutics and Pharm. Tech. Gombe State University, Gombe, Nigeria.
Abstract:
The 2026 Ebola outbreak caused by Bundibugyo ebolavirus in the Democratic Republic of the Congo and Uganda exposes a persistent structural flaw in global health security: preparedness remains overwhelmingly reactive and pathogen-specific. Despite the $518 million Africa CDC-WHO joint continental plan, no licensed BDBV vaccine or therapeutic is available; a 21-day (three-week) detection delay and cross-border transmission expose inadequate inter-epidemic investment in non-Zaire ebolavirus countermeasures. We argue for sustained, ring-fenced financing, institutionalised cross-border coordination, species-inclusive diagnostics, and real-time genomic data sharing to move African Ebola preparedness from reactive to pre-emptive.
Related Concept Videos
Cross-reactivity
Steps in Outbreak Investigation
Smallpox
Investigation of Disease Outbreaks
Infectious Diseases and Their Occurrence
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
